Organization · Venture Capital
Anzu Partners
Anzu Partners is a venture capital firm that invests in breakthrough industrial and life science technologies. With a focus on early-stage companies, it operates across North America, Europe, and Asia Pacific.
Overview
What Anzu Partners does
What Anzu Partners is
Anzu Partners is a venture capital firm that invests in breakthrough industrial and life science technologies. With a focus on early-stage companies, it operates across North America, Europe, and Asia Pacific.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2014
- Approximate age
- About 12 years
- Structured capabilities
- Funder
- Last reviewed
- March 7, 2026
Official channels
Find Anzu Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Anzu Partners as a funder
Investment thesis
Anzu Partners focuses on breakthrough industrial and life science technologies that have the potential to transform their respective industries. The firm employs a multi-structure investment approach, including venture capital, private credit, and public market investments.
Focus narrative
Anzu Partners invests in clean technology, industrial, and life science technologies. The firm provides capital and expertise in business development, market positioning, global connectivity, and operations. Their investment strategy includes early-stage venture capital and non-dilutive preferred share vehicles for post-revenue companies, aiming to identify high-quality businesses with transformative technologies.
Value beyond capital
Anzu Partners adds value to its portfolio companies through deep industrial expertise and a hands-on approach, providing support in business development, market positioning, and operational efficiency, beyond just capital investment.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B
- Regions
- AsiaEuropeNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 35
Portfolio context
Anzu Partners has a diverse portfolio of approximately 35 companies, including notable firms such as 6K, which develops advanced plasma processing systems; Banyan Biomarkers, known for the first FDA-approved blood test for mild traumatic brain injuries; and Carisma Therapeutics, focused on engineered macrophage therapies for solid tumors.
Common questions
What to know about Anzu Partners
Upseed classifies Anzu Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 7, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.